While the prognosis of patients presenting with de novo atrial fibrillation (AF) during the acute phase of myocardial infarction has been controversially discussed, it seems intuitive that affected individuals have an increased risk for both thrombo-embolic events and mortality. However, profound data on long-term outcome of this highly vulnerable patient population are not available in current literature. Therefore, we aimed to investigate the impact of de novo AF and associated anti-thrombotic treatment strategies on the patient outcome from a long-term perspective.

中文翻译：

---

急性心肌梗死期间新发心房颤动的长期预后：抗血栓治疗策略的影响

虽然对心肌梗死急性期新发心房颤动 (AF)患者的预后进行了有争议的讨论，但受影响的个体血栓栓塞事件和死亡率的风险增加似乎很直观。然而，目前的文献中没有关于这一高度脆弱患者群体长期结果的深刻数据。因此，我们旨在从长期角度研究新发 AF 和相关抗血栓治疗策略对患者预后的影响。